28 June 2020>: Lab/In Vitro Research
Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts
Ling He BCDE* , Song Guo BC* , Taiyang Zhu BCD* , Chen Chen ADEF* , Kun Xu ABC*DOI: 10.12659/MSM.922561
Med Sci Monit 2020; 26:e922561
Figure 6 The inhibitory effect of the paeonol-platinum(II) (PL-Pt[II]) complex on mouse SW1736 cell tumor xenografts in vivo. (A) PL-Pt(II) (2 mg/kg) gavage was given daily for 21 days to the mice bearing the SW1736 cell xenografts, which reduced tumor volume. (B) The toxicity of PL-Pt(II) in vivo was evaluated by measuring body weight during the study. (C) The effect of PL-Pt(II) on p-AKT, p-S6, caspase-3, and p-S6 in the mouse tumor xenografts were detected by Western blot. * P<0.05, ** P<0.02 and *** P<0.01 vs. Day 0.